Effect of low-calcium and standard-calcium dialysate on serum calcium, phosphorus and full-segment parathyroid hormone in patients on peritoneal dialysis: A retrospective observational study

被引:1
作者
An, Ning [1 ]
Zhou, Haishan [1 ]
Li, Xianhui [1 ]
Yu, Xinyin [1 ]
Yang, Haijuan [1 ]
Zhai, Liping [1 ]
Huang, Yuhua [1 ]
Yao, Cuiwei [1 ,2 ]
机构
[1] Guangdong Med Univ, Affiliated Hosp, Dept Nephrol, Zhanjiang, Peoples R China
[2] Guangdong Med Univ, Dept Nephrol, Affiliated Hosp, 57th South Renmin Rd, Zhanjiang 524001, Guangdong, Peoples R China
关键词
Chronic kidney disease; serum calcium; serum phosphorus; peritoneal dialysis; vascular calcification; low-calcium dialysis; CHRONIC KIDNEY-DISEASE; RISK; CALCIFICATION; PROGRESSION; PHOSPHATE;
D O I
10.1177/03913988231206641
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To investigate the effects of low-calcium and standard-calcium dialysate in patients with chronic kidney disease on peritoneal dialysis, and find out which dialysate has less vascular calcification effect.Methods: A total of 141 patients who had undergone peritoneal dialysis (PD) for 2 years in the PD centre from January 2012 to December 2017 were included and divided into two groups according to the calcium concentration of the PD fluid used. There were 79 cases in the low-calcium group, with a dialysate calcium concentration of 1.25 mmol/L and 62 cases in the standard-calcium group, with a dialysate calcium concentration of 1.75 mmol/L. The demographic characteristics and clinical information before initiation of PD were collected and compared between the two groups. Information on the serum calcium, phosphorus and PTH, systolic and diastolic blood pressures and the use of antihypertensive and phosphate-lowering drugs in the second year of dialysis was also collected and compared between the two groups. Vascular calcification was assessed in patients on PD treatment.Results: The mean serum calcium concentrations before initiation of PD in the low- and standard-calcium groups were 1.94 +/- 0.27 and 1.89 +/- 0.28 mmol/L, respectively. The serum calcium concentrations after PD were 2.30 +/- 0.21 and 2.41 +/- 0.23 mmol/L, respectively. After PD, the serum calcium concentration in both groups was significantly increased (p < 0.05). The serum calcium concentration in the low-calcium group after PD treatment was lower than that in the standard-calcium group, and the difference was statistically significant (p < 0.05). Compared with the standard-calcium group, patients in the low-calcium group had significantly higher parathyroid hormone concentrations (p < 0.05). More types of phosphate-lowering drugs were used (59.49%) in the low-calcium group than that in the standard-calcium group (35.48%; p < 0.05). The number of antihypertensive drug usage were also higher in the low-calcium group, and the difference was statistically significant (p < 0.05). As for the vascular calcification effect, the two groups have shown no statistical difference in abdominal aortic calcification rate, carotid arteriosclerosis rate and aortic arch calcification rate (p < 0.05).Conclusion: We found that low-calcium PD fluid may increase the PTH level and the proportion of CKD patients using antihypertensive drug and phosphorus-lowering drug, but the vascular calcification effect of the low and standard calcium PD fluid needs further exploration. This paper provides new evidence for the choice of dialysate for PD, low-calcium dialysate has no outstanding advantages for long term dialysis.
引用
收藏
页码:539 / 546
页数:8
相关论文
共 32 条
  • [1] Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
    Adeney, Kathryn L.
    Siscovick, David S.
    Ix, Joachim H.
    Seliger, Stephen L.
    Shlipak, Michael G.
    Jenny, Nancy S.
    Kestenbaum, Bryan R.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (02): : 381 - 387
  • [2] The influence of blood pressure patterns on renal outcomes in patients with chronic kidney disease The long-term follow up result of the APrODiTe-2 study
    Cha, Ran-hui
    Lee, Hajeong
    Lee, Jung Pyo
    Kim, Yon Su
    Kim, Sung Gyun
    [J]. MEDICINE, 2020, 99 (08)
  • [3] Peritoneal Dialysis
    Cruz Andreoli, Maria Claudia
    Totoli, Claudia
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 : S37 - S44
  • [4] Demirci MS., 2009, PERIT DIAL INT, V29
  • [5] El Baz TZ, 2017, EGYPT HEART J, V69, P149, DOI 10.1016/j.ehj.2017.02.004
  • [6] He YQ., 2017, J SE U, V36, P1009
  • [7] Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta -analysis
    Huang, Caleb Weihao
    Wee, Poh Hui
    Low, Lian Leng
    Koong, Ying Leng Agnes
    Htay, Htay
    Fan, Qiao
    Foo, Wai Yin Marjorie
    Seng, Jun Jie Benjamin
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2021, 69 : 27 - 40
  • [8] Low-calcium dialysate as a risk factor for decline in bone mineral density in peritoneal dialysis patients
    Kang, Seok Hui
    Cho, Kyu Hyang
    Park, Jong Won
    Yoon, Kyung Woo
    Do, Jun Young
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2012, 46 (06): : 454 - 460
  • [9] New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study
    Kauppila, LI
    Polak, JF
    Cupples, LA
    Hannan, MT
    Kiel, DP
    Wilson, PWF
    [J]. ATHEROSCLEROSIS, 1997, 132 (02) : 245 - 250
  • [10] Serum phosphate levels and mortality risk among people with chronic kidney disease
    Kestenbaum, B
    Sampson, JN
    Rudser, KD
    Patterson, DJ
    Seliger, SL
    Young, B
    Sherrard, DJ
    Andress, DL
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02): : 520 - 528